Concepedia

Publication | Open Access

The oncolytic adenovirus TILT-123 with pembrolizumab in platinum resistant or refractory ovarian cancer: the phase 1a PROTA trial

15

Citations

31

References

2025

Year

References

YearCitations

Page 1